Employers have started to focus on fulfilling opportunities to control costs and supplying more services to help employees understand their treatment options and the healthcare system as a whole, explained Brian Marcotte, president and CEO of the National Business Group on Health.
Employers have started to focus on fulfilling opportunities to control costs and supplying more services to help employees understand their treatment options and the healthcare system as a whole, explained Brian Marcotte, president and CEO of the National Business Group on Health.
Transcript (slightly modified)
In what ways are employers taking initiative on their own to help reduce costs and improve the experience of their employees when they get care?
I think employers the last several years have been more focused on demand-side changes and opportunities to control costs. So, you’ve seen a lot of movement to consumer-directed health plans, you’ve seen the implementation of transparency tools, telehealth, decision support—all in an effort to help a consumer make better decisions.
I think the realization is that it’s very difficult to turn an employee into a sophisticated consumer of healthcare. They don’t touch the market enough, the market is too complicated, too fragmented, so they are beginning to shift, both in terms of a focus on the delivery systems—so you are seeing the emergence of more activity with ACOs, and high-performance networks, and centers of excellence.
But, employers are also doing more around advocacy, around navigation, around concierge-type services, to help employees both understand what their treatment options are and how to navigate the system and what’s the best place for care. Then even going to personalization to try to reach people in the moment to engage them so they can optimize the resources that they have.
Inside the Center's MDD Value Model and Its Use of Dynamic Pricing
May 13th 2025Larragem Raines, MS, of the Center for Innovation & Value Research, discusses the organization's major depressive disorder (MDD) open-source value model, dynamic pricing, and the future role of artificial intelligence in care.
Listen
Tailored Dosing for MM Matters More Than Drug Count: Ajai Chari, MD
April 25th 2025When it comes to treating multiple myeloma (MM), Ajai Chari, MD, argued that more is not always better. More intense treatment regimens, or those with more drugs, don't necessarily guarantee better outcomes.
Read More
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More